<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02652000</url>
  </required_header>
  <id_info>
    <org_study_id>KEK-ZH-Nr. 2015-0573</org_study_id>
    <nct_id>NCT02652000</nct_id>
  </id_info>
  <brief_title>Quality of Life After Permanent Interstitial Iodine Seed Prostate Brachytherapy</brief_title>
  <official_title>Retrospective Analysis of Quality of Life After Permanent Interstitial Iodine Seed Brachytherapy for Prostate Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kantonsspital Graubuenden</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Kantonsspital Graubuenden</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Retrospective study to analyze Quality of life in men after iodine seed brachytherapy for
      localized prostate cancer
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Retrospective Evaluation of Quality of life data collected on men who underwent iodine seed
      brachytherapy at the University Hospital Zurich
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>CTCAE v4.03ff Grade 1-4 Sexual/Reproductive Function</measure>
    <time_frame>5 years (2009-2014)</time_frame>
    <description>Scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>CTCAE v4.03ff Grade 1-4 Gastrointestinal</measure>
    <time_frame>5 years (2009-2014)</time_frame>
    <description>Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CTCAE v4.03ff Grade 1-4 Renal/Genitourinary</measure>
    <time_frame>5 years (2009-2014)</time_frame>
    <description>Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>International Prostate Symptom Score (IPSS)</measure>
    <time_frame>5 years (2009-2014)</time_frame>
    <description>Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>International Index of erectile function, five items (IIEF-5)</measure>
    <time_frame>5 years (2009-2014)</time_frame>
    <description>Scale</description>
  </secondary_outcome>
  <enrollment type="Actual">50</enrollment>
  <condition>Neoplasms, Prostate</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention in this retrospective study</intervention_name>
    <description>No Intervention in this retrospective Analysis.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients having had idodine seed brachytherapy for localized prostate cancer between 2009
        and 2014
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male &gt; 18 years of age

          -  iodine seed brachytherapy for localized prostate cancer at the University Hospital
             Zurich

        Exclusion Criteria:

          -  No iodine seed brachytherapy for localized prostate cancer at the University Hospital
             Zurich
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>48 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel R Zwahlen, MD, MBA</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kantonsspital Graubuenden</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kantonsspital Graubuenden, Department of Radiaton Oncology</name>
      <address>
        <city>Chur</city>
        <zip>7000</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 6, 2016</study_first_submitted>
  <study_first_submitted_qc>January 7, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 11, 2016</study_first_posted>
  <last_update_submitted>December 11, 2016</last_update_submitted>
  <last_update_submitted_qc>December 11, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 13, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kantonsspital Graubuenden</investigator_affiliation>
    <investigator_full_name>Daniel Rudolf Zwahlen</investigator_full_name>
    <investigator_title>MD, MBA</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

